More Than Microscopes: the DIFFERENCE CANADIANS MAKE SAVING LIVES THROUGH MEDICAL RESEARCH

Total Page:16

File Type:pdf, Size:1020Kb

More Than Microscopes: the DIFFERENCE CANADIANS MAKE SAVING LIVES THROUGH MEDICAL RESEARCH More Than Microscopes: THE DIFFERENCE CANADIANS MAKE SAVING LIVES THROUGH MEDICAL RESEARCH healthpartners.ca 150 YEARS … 150 MEDICAL RESEARCH ADVANCES … $150 MILLION RAISED: Canadian Researchers Make a Mark Here — and Around the World Rick Perciante, Chair, Eileen Dooley Board of Directors CEO, HealthPartners HealthPartners Pablum to improve infant nutrition. The ability of Without a breakthrough using stem cell-based T-cells to destroy bacteria and viruses and marshal therapy to treat aggressive forms of relapsing- the immune system. The Cobalt-60 ‘bomb’ to remitting multiple sclerosis, Jennifer Molson kill cancer cells. Controlled gene mutation. The wouldn’t have been able to participate in a link between stress and disease. Insulin to treat bone marrow transplant trial, which essentially diabetes. Child-resistant medical containers. transformed her life. Without ground-breaking Discovery of stem cells. drug therapies, eight-year-old Kaiden Ames would probably not be alive today, and his Despite an overall population of fewer than parents wouldn’t have the chance to see him 40 million, Canada has nurtured a striking number grow up and even be a parent himself. Without of scientists and researchers whose breakthrough deep brain stimulation surgery, Herb Durand medical discoveries — and their ongoing wouldn’t be able to fulfill a long-time dream: to contributions to medical knowledge — have hold his grandchild. And without the tremendous improved, or have the potential to improve, the strides that have been made in diabetes research, health of millions of people around the world, not Dwayne Vermette certainly wouldn’t be living a just across our vast country. healthy lifestyle after being diagnosed with type 2 diabetes in his 30s — including having the ability HealthPartners is proud to play a leadership role to manage his condition with pills rather than a in connecting donor dollars to life-enhancing and daily injection of insulin. life-changing research that makes a real difference in the health of Canadians. Given that nine out Our scientists have not only changed the lives of of 10 of us, living in neighbourhoods across this thousands of Canadians like Jennifer, Kaiden, Herb country, are touched by a major disease or chronic and Dwayne; they’ve made a mark internationally. illness, the value of the research that our member They’ve ushered in the age of modern nuclear charities support — thanks to the generosity of medicine, opened up the field of biotechnology, our donors — cannot be underscored. pioneered cell-based therapy, designed medical equipment, invented new surgical and treatment And our donors have been incredibly generous. techniques, developed drugs and vaccines, The $150 million raised through HealthPartners, and more — collecting seven Nobel prizes in coupled with other direct donations to our the process. charities, have given legions of Canadians support, dignity, hope — and even their lives. In terms of the amount of money we spend on research, we may rank 14th among 31 Western Through the pages of More Than Microscopes, industrialized nations, but we rank 6th in the we’ve chosen to highlight 150 achievements quality of our research. When it comes to world- that have advanced the field of medical research. changing research, Canada truly does punch These achievements are among hundreds that above its weight. have helped to move the research yardstick forward — and in the process, improving lives, Research excellence speaks to a culture that transforming lives and saving lives. supports innovation — to go where no-one has gone before. They also serve to showcase the tremendous research that is being undertaken by researchers In the area of medical innovation, HealthPartners’ and scientists who are supported by our 16 member health charities play a major role 16 member health charities. Their ground- in nurturing our country’s innovative research breaking and ground-blazing work is a cause culture. Through annual funding commitments, for celebration — and a concrete testament to our charities support the ability of researchers what can be achieved when Canadians lend from coast to coast to coast to exercise their their support to medical research. Through the creative research muscle. With scientific curiosity incredible support of donors to HealthPartners and intellectual know-how, these researchers and our charities — $150 million raised and delve into uncharted territory, propelled by a counting — we truly can achieve so much when it desire to save lives. And they do. comes to helping Canadians live healthy lives. Here’s to the next 150 years! 2,500 to 3,000 Canadians over ALS Research the age of 18 have ALS First described in the 19th century, ALS, or amyotrophic lateral 2 out of every 100,000 people sclerosis, is a disease that gradually paralyzes the body, leaving people diagnosed with ALS every year without the ability to move, talk, swallow and eventually, breathe. Most people die within two to five years of being diagnosed with ALS 80% of people who have ALS because the disease has no effective treatment or cure. die within 2 to 5 years of their diagnosis However, ALS research has made more progress in the last 5 to 7 years than in the last century, advancing to a point which many ALS research experts believe effective treatments are now a matter of ‘when’ not ‘if.’ NIGEL VAN LOAN Nigel Van Loan’s wife, Patricia, passed away in 2007 from ALS, a terminal neurodegenerative disease that also took the lives of her mother and three sisters. Although she was relieved to have a diagnosis, she was overcome with fear, dread and panic — “I really didn’t know how I could live with ALS without going mad,” she wrote on the ALS Canada website. Patricia was able to live at home until her death thanks to the progress that had been made in ALS research into equipment loaned by the Society that kept her mobile, was used to transport her up and down the stairs, and enabled her to shower, bathe and get out of bed. After Patricia’s passing, Nigel became active in ALS Canada and remains a member of the ALS client services committee, lobbying the government for research dollars and fundraising for the Society as a way to keep his wife’s memory alive — and because ALS is in his family (his two sons and his grandchildren could carry the gene). Research Advances Through the Years: Highlights 2008: Stefano Stifani uncovers a key mechanism involved in the development of motor neurons, Canada is considered a leader in ALS improving our understanding of what goes wrong in neurodegenerative diseases such as ALS. research — consistently in the top five countries for ALS discoveries. Nicolas Dupré is part of the team that discovers the gene TDP-43 is involved in ALS. 2012: Michael Strong and his team discover a Current research studies include: new gene responsible for hereditary ALS. • replacing bone marrow cells with new cells containing potentially protective genes 2014: Michael Strong demonstrates that a large • as part of the first large imaging study in the number of miRNA are altered in ALS. world, exploring advanced MRI methods that can be used as a biomarker, making it possible Researcher Spotlight for physicians to detect the disease earlier, Robarts scientist and neurologist monitor disease progression and evaluate Michael Strong is a world leader new therapies in the search for a cure for ALS. • studying whether the most common genetic He balances his research work abnormality in ALS, which occurs in the with frontline clinical care of C90RF72 gene, causes or contributes to patients affected by the disease, the disease working with one of the largest research-based • studying the role of interneurons, which ALS clinics in Canada. Dr. Strong’s relentless work connect to motor neurons in the brain, in the moving from inquiry to insight and repeating that early stages of ALS process throughout his career has produced a series of new scientific discoveries in the ALS field. Founded in 1977, ALS Canada and its provincial partners are dedicated to supporting Canadians living with ALS and investing in research to make ALS a treatable, not terminal, disease. Through the ALS Canada Research Program, ALS Canada funds peer-reviewed research grants, fosters collaboration and builds capacity within Canada’s ALS research community, and participates in new areas of research. Since 2014, ALS Canada has invested approximately $20 million into ALS research. The Society also supports Project MinE, a multinational initiative involving more than 15 participating countries, where the goal is to establish a global resource of human data that will enable scientists to understand the genetic signature that leads someone to develop ALS. The Canadian component of Project MinE brings together four of Canada’s leading ALS geneticists — Ian Mackenzie, Vancouver; Ekaterina Rogaeva, Toronto; Guy Rouleau, Montreal; and Nicolas Dupré, Quebec City — for their first ever cross-country collaboration. 564,000 Canadians live Alzheimer’s Disease Research with dementia By 2038, over 1 million Canadians will be living with dementia, largely 25,000 more Canadians are because the baby boom generation will have reached old age. diagnosed every year We still don’t understand exactly how Alzheimer’s disease damages 937,000 Canadians will have the brain — somehow cells are damaged and eventually die in dementia in less than 15 years different areas of the brain. The death of brain cells leads to dementia, For every person with dementia, characterized by memory loss, impaired judgment and behavioural 1 or more family members changes. But what we do know is that Alzheimer’s usually affects provide care at least two lives: the person with the condition, and the person’s spouse or child, who gradually becomes a full-time caregiver as the disease progresses. On June 22, 2017, Canada became Because there is currently no cure for Alzheimer’s, treatment focuses the 30th country to launch a national on relieving symptoms and maintaining the quality of the person’s life.
Recommended publications
  • Il Est Un Petit Honneur «Qui Fait Grand Plaisir!» Michèle Thibodeau-Deguire a Accédé À L’Académie Des Grands Montréalais En 2001
    LE DEVOIR, LE MERCREDI 16 NOVEMBRE 2011 MONTREAL CAHIER C LES GRANDS MONTRÉALAIS Sid Stevens Frédéric Back Pierre Fortin est le Grand Montréalais devient à 87 ans et Aldo Bensadoun en 2011 le Grand Mont- rejoignent du secteur social réalais culturel la communauté Page 3 Page 5 Pages 4 et 6 JACQUES NADEAU LE DEVOIR Centraide encourage le développement du réseau des intervenants au sein de chaque quartier de Montréal. Il est un petit honneur «qui fait grand plaisir!» Michèle Thibodeau-DeGuire a accédé à l’Académie des Grands Montréalais en 2001 En 2001, Michèle Thibodeau-DeGuire, présidente et directri- police, l’école, les organismes communautaires, le CLSC, etc., ce générale de Centraide du Grand Montréal, s’est vu décer- travaillent dans le même sens ner le titre de Grand Montréalais, un honneur qui lui a fait pour trouver des solutions avec réellement plaisir. «C’est très, très, très excitant, lance tout à les citoyens, indique Mme Thi- fait joyeusement cette Acadienne de souche. C’est probable- bodeau-DeGuire. Nous finan- çons donc des tables de concerta- ment même, de tous les honneurs que j’ai reçus, celui qui tion depuis près de vingt ans, m’a le plus touchée!» afin de réunir les divers interve- nants pour qu’ils s’entendent sur CLAUDE LAFLEUR l’un ou l’autre des quatre les priorités de leur quartier. La champs d’activité — écono- table réunit ceux qui possèdent ela m’a même mique, social, culturel et une partie de la solution, ce qui surprise, se scientifique. Il y a ensuite un a déjà tout un impact.» « souvient Mi- petit groupe qui se réunit chèle Thibo- pour établir une courte liste 2011 sera deau-DeGuire, — trois ou quatre noms par une bonne année nomméeC «Grande Montréalai- secteur d’activité.
    [Show full text]
  • Universidad Autónoma De Madrid
    UNIVERSIDAD AUTÓNOMA DE MADRID DEPARTAMENTO DE BIOLOGÍA MOLECULAR Identification and functional characterization of epigenetic determinants of pancreatic CSCs Sladjana Zagorac Madrid, 2015 DEPARTAMENTO DE BIOLOGÍA MOLECULAR FACULTAD DE CIENCIAS UNIVERSIDAD AUTÓNOMA DE MADRID Identification and functional characterization of epigenetic determinants of pancreatic CSCs Sladjana Zagorac Licenciatura en Biología Molecular y Fisiología Director de Tesis: Prof. Christopher Heeschen, M.D. PhD Centro de células madre en el cáncer y el envejecimiento Barts Instituto de Cancer (BCI) This thesis, submitted for the degree of Doctor of Philosophy at the Universidad Autónoma de Madrid, has been completed in the Stem Cells & Cancer Group at the Spanish National Cancer Research Centre (CNIO) and Centre for Stem Cells in Cancer and Ageing, Barts Cancer Instutute (BCI) under the supervision of Prof. Dr. Christopher Heeschen. Dedicated to my parents, my sister Ivana and my friends who always supported me. ACKNOWLEDGEMENTS It is strange to look back in time and see myself entering true the door of CNIO my first day in Christopher’s laboratory back in October 2010. For some maybe little and for other’s so much. Thank you Christopher for replaying to my email and opening me the door of your lab! It was just a start of an incredible journey that led me where I am now, and that will mark my next trails to run. So many people I need to mention and say thanks for their unconditional help and support. Enza thank you for accepting me as your student and for being patient with me. I will never forget how you would always tell me to think why I am doing things.
    [Show full text]
  • University of Toronto University-Wide Impact Presentation
    UNIVERSITY OF TORONTO UNIVERSITY-WIDE IMPACT PRESENTATION INTRO: .......................................................................................... 2 SECTION 1: GLOBAL FOOTPRINT .............................................. 3 SECTION 2: INNOVATION AND IMPACT .................................... 15 SECTION 3: EXCELLENCE AND LEADERSHIP IN SOCIETY ..... 31 Text is not editable on animation slides. Updated May 2021 ON-SCREEN IMAGE SPEAKER’S NOTES BEGINNING OF PRESENTATION [Good afternoon]. My name is [X], and I serve as [X] at the University of Toronto. Thank you for joining us [today]. [Today] I would like to take you through a presentation that speaks to the crucial role that U of T is honoured to play in our communities and our world. U of T is a world-leading university with three campuses in the Greater Toronto Area. We provide students with a comprehensive global education, produce life-changing research, and promote economic growth and social progress in our communities. I’m going to cover three aspects: • U of T’s Global Footprint • U of T’s Innovation and Impact • U of T’s Excellence and Leadership in Society Since its very early days, U of T has been fortunate to have forged connections with institutions around the world and to have welcomed faculty and students from elsewhere to become part of the U of T community. Today, U of T’s global footprint is significant. 2 SECTION 1 GLOBAL FOOTPRINT 3 ON-SCREEN IMAGE SPEAKER’S NOTES We are immensely proud of our worldwide alumni community. Over 630,000 U of T alumni live, work and contribute to civil society in more than 190 countries and territories. Few universities in the world can rival the cultural diversity of our student population.
    [Show full text]
  • Radiation Medicine Program
    Radiation Medicine Program ANNUAL 2020 REPORT 2021 VALUES MISSION Innovation Advance exemplary radiation Excellence medicine through patient Collaboration care, research & education Accountability in partnership with CONTENTS Integrity our patients & community 4 A Message from the Chief 6 Program Overview 7 2020: The Year in Numbers 8 Strategic Roadmap to 2026 VISION 10 Clinical Care CURE EVOLVE 15 Quality & Safety Predictive Health & Precision Radiation Medicine. Advanced Particle Adaptive Radiotherapy Therapy & Theranostics 18 Education Personalized Care. 21 Research Global Impact. 26 Team RMP COMFORT & CONNECT Systems to Maximize CONFIDENCE Innovation & Wellbeing Technology-enabled Patient Experience Transformation A MESSAGE FROM THE CHIEF The Radiation Medicine Program (RMP) at the Princess Margaret Cancer Centre is committed to delivering the highest standard of patient care. Over the RMP’s innovative education programs continue to thrive and attract a diverse group of national and international attendees. Our award-winning Accelerated past year, our dynamic multidisciplinary team of radiation oncologists, medical physicists, radiation therapists, administrators, and support staff have worked Education Program (AEP) demonstrated extraordinary resourcefulness this past year, standing strong amidst the pandemic, and continuing to provide top- together to advance our vision of “Precision Radiation Medicine. Personalized Care. Global Impact.” RMP continues to uphold our foundational values of level education to a broad spectrum of learners.
    [Show full text]
  • Health Matters Fall 2017
    THE OTTAWA VALLEY’S HEALTH MAGAZINE HealthMattersFREE! FALL 2017 Eating With A Happy Heart: Advice from the authors of Looneyspooons Local Canadian Experts Health Feature Facts Section: FOOD! Kids Lunch Church Suppers Hacks Around The County! Saving Silas: Meet a little boy who was The Food born with the will to live Crossword In honour of Canada’s 150th, we Canada 150 are trying to attract 150 aircraft to fly-in to the airport on one day! FLY-IN Come Join Us! Thi s goi is g n to be a very o c ay. ol d September 23rd | 10am-3pm This is a FREE event to attend. Pembroke & Area Lunch is available for purchase. AIRPORTT Plus: Ry-J’s, Aircraft Simulator, 49 Years in Aviation. and Canadian Forces aircraft on display! Easy parking in the Expo 150 field across from the airfield. Seating available at the airfield. Meet local and visiting pilots who are flying-in on this special day. 176 Len Hopkins Drive, Petawawa. Visit www.flycyta.ca/Canada150 or www.facebook.com/flycyta. Pembroke & Area AIRPORTT 49 Years in Aviation. FROM THE PUBLISHER FALL 2017 A Letter From Audrey Reader’s handwritten letter says it best about the Health Matters vision as we complete our fifth year After our last issue, I received a handwritten Ottawa Valley, even lifetime residents are letter in the mail from a woman named Audrey. unaware of! You do an excellent job of It was so compelling that I realized I could not bringing them to light, so more residents can do a better job than she did for the Publisher’s use them to make their lives better.
    [Show full text]
  • Maud Menten, a Physician and Biochemist
    Maud Menten Canadian medical researcher Maud Menten (1879-1960) has been called the "grandmother of biochemistry," a "radical feminist 1920s flapper," and a "petite dynamo." Not only was she an author of Michaelis-Menten equation for enzyme kinetics (like the plot in indigo in my portrait), she invented the azo-dye coupling for alkaline phosphatase, the first example of enzyme histochemistry, still used in histochemistry imaging of tissues today (which inspired the histology background of the portrait), and she also performed the first electrophoretic separation of blood haemoglobin in 1944! Born in Port Lambton, Ontario, she studied at the University of Toronto, earning her bachelor's in 1904, and then graduated from medical school (M.B., bachelor's of medicine) in 1907. She published her first paper with Archibald Macallum, the Professor of Physiology at U of T (who went on to set up the National Research Council of Canada), on the distribution of chloride ions in nerve cells in 1906. She worked a year at the Rockefeller Institute in New York, where along with Simon Flexner, first director of the Institute, she co-authored a book on radium bromide and cancer, the first publication produced by the Institute - barely 10 years after Marie Curie had discovered radium. She completed the first of two fellowships at Western Reserve University (now Case Western Reserve University), then she earned a doctorate in medical research in 1911 at U of T. She was one of the first Canadian women to earn such an advanced medical degree. She then moved to Berlin (travelling by boat, unfazed by the recent sinking of the Titanic) to work with Leonor Michaelis.
    [Show full text]
  • Department of Medicine Annual Report 2018-2020 Cover: Dr
    Department of Medicine Annual Report 2018-2020 Cover: Dr. Verdu and her Research Team Top row: Dr. Heather Galipeau, Dr. Elena Verdu Middle row: Dr. Xuanyu Wang, Dr. Alba Santiago Bottom row: Dr. Marco Constante, Dr. Josie Libertucci A United Team with a common purpose: Dr. Verdu’s Research Team investigates diet-microbiota In addition to being committed to research excellence, this team interactions in chronic intestinal disorders. The team’s line of is committed to each other and to the wellbeing of others. The research includes: the metabolic activity of gut bacteria on the members of this high performing team have been consistent digestion of the dietary protein and gluten, the role of proteolytic supporters of charity events to raise awareness and funds for imbalance in ulcerative colitis, and the contribution of proteolytic the “Canadian Digestive Health Foundation” and “Crohn’s and bacteria to colonic inflammation. The team also explores Colitis of Canada” research, recently surpassing their target mechanisms through which microbes can modulate intestinal fundraising goal at the last virtual GUTSY Walk 2021event. As a inflammation and mechanisms that could help develop therapies to collective team, they have weathered the COVID-19 pandemic and treat celiac disease, and ulcerative colitis. have come together on this cover to illustrate that their common purpose and “united team” approach has not wavered even in this virtually connected world. Our Goals To facilitate the provision of the highest possible quality of care of the medical diseases of adults, giving appropriate consideration to costs and utilities. To take responsibility for the quality of the education programs offered by McMaster University for physicians in training and practice in the disciplines of general internal medicine and the medical subspecialities and to provide many of the planners and teachers for this broad undertaking.
    [Show full text]
  • The Science of Defence: Security, Research, and the North in Cold War Canada
    Wilfrid Laurier University Scholars Commons @ Laurier Theses and Dissertations (Comprehensive) 2017 The Science of Defence: Security, Research, and the North in Cold War Canada Matthew Shane Wiseman Wilfrid Laurier University, [email protected] Follow this and additional works at: https://scholars.wlu.ca/etd Part of the Canadian History Commons, History of Science, Technology, and Medicine Commons, and the Military History Commons Recommended Citation Wiseman, Matthew Shane, "The Science of Defence: Security, Research, and the North in Cold War Canada" (2017). Theses and Dissertations (Comprehensive). 1924. https://scholars.wlu.ca/etd/1924 This Dissertation is brought to you for free and open access by Scholars Commons @ Laurier. It has been accepted for inclusion in Theses and Dissertations (Comprehensive) by an authorized administrator of Scholars Commons @ Laurier. For more information, please contact [email protected]. The Science of Defence: Security, Research, and the North in Cold War Canada by Matthew Shane Wiseman B.A. (Hons) and B.Ed., Lakehead University, 2009 and 2010 M.A., Lakehead University, 2011 DISSERTATION Submitted to the Department of History in partial fulfillment of the requirements for Degree in Doctor of Philosophy in History Wilfrid Laurier University Waterloo, Ontario, Canada © Matthew Shane Wiseman 2017 Abstract This dissertation examines the development and implementation of federally funded scientific defence research in Canada during the earliest decades of the Cold War. With a particular focus on the creation and subsequent activities of the Defence Research Board (DRB), Canada’s first peacetime military science organization, the history covered here crosses political, social, and environmental themes pertinent to a detailed analysis of defence-related government activity in the Canadian North.
    [Show full text]
  • Stem Cell Strategy by Establishing the Till & Mcculloch Medicines of Tomorrow Innovation Fund
    A Pre-Budget Submission to the House of Commons Standing Committee on Finance To Implement the Canadian Stem Cell Strategy By Establishing The Till & McCulloch Medicines of Tomorrow Innovation Fund James Price President & CEO Canadian Stem Cell Foundation February 9, 2016 EXECUTIVE SUMMARY Stem cells represent the biggest innovation in medicine of the last half century. These cells have the power to cure many diseases for which current medical practice can only provide symptomatic relief and chronic care – a reality that is straining health care systems in Canada and in countries around the globe. Stem cells are a hallmark of Canadian innovation. They were first discovered in Canada and Canada is one of the top three countries in stem cell R&D, with our scientists ranking among the best in the world. Recent investments, such as the Government’s $20-million commitment to establish a cell-manufacturing facility in Toronto and the $114-million Medicine By Design grant for the University of Toronto, will help Canada move forward. However, major commitments by competitor jurisdictions – most notably California, with its investment of $3 billion, and Japan, with an investment of $1 billion in stem cells and regenerative medicine -- challenge Canada’s leadership in this sector of the knowledge economy. Moreover, Canada lacks a national plan to succeed in the coming cell therapy and regenerative medicine boom. The Canadian Stem Cell Strategy -- created in consultation with 150 scientists, medical doctors, leaders from major health charities, industry experts, investors and philanthropists – will: • deliver up to 10 new curative therapies within 10 years; • transform health care and ease the strain on the health system; and • attract private investment and generate 12,000 jobs for Canadians.
    [Show full text]
  • A Comparative Study of Canada and Mexico.” Studies in History and Philosophy of Biological and Biomedical Sciences (71), 8-16
    William Leeming and Ana Baharona. 2018. “Synthesis, Convergence and the Early Adoption of Cytogenetics in Medicine: A Comparative Study of Canada and Mexico.” Studies in History and Philosophy of Biological and Biomedical Sciences (71), 8-16. (Accepted Author Version) Authors: William Leeming and Ana Baharona Title: Synthesis, Convergence and Differences in the Entangled Histories of Cytogenetics in Medicine: A Comparative Study of Canada and Mexico Abstract: It is now commonplace for historians to say medical genetics began around sixty years ago with the synthesis and convergence of human genetics and cytological techniques in European centres which, in turn, were disseminated to centres in the United States in a more or less straightforward manner to become a new field of expertise in medicine and clinical research, i.e., cytogenetics. In this article, we show how the early histories of cytogenetics in Canada and Mexico unfolded against strikingly different backgrounds in clinical research and the delivery of health care. A key argument follows that the field of cytogenetics did not necessarily come together and develop the same way in all countries. The article begins with a brief background to the history of human cytogenetics. There follows two sections outlining the early adoption of cytogenetics in Canada and Mexico. Conclusions are then drawn using comparisons of the different ways local determinants affected adoption. This leads, in a final step, to suggestions for directions for future study concerning the ways circuits of practices, collaborative research, and transfers of knowledge have shaped the ways that cytogenetics has been organised in medicine around the world. Keywords: Medical Genetics, Cytogenetics, Karyotyping, Transnational perspective on history, Entangled histories 1 1.
    [Show full text]
  • 2011 Gairdner Foundation Annual Report
    2011 GAIRDNER FOUNDATION ANNUAL REPORT May 30, 2012 TABLE OF CONTENTS TABLE OF CONTENTS ...................................................................................................................................... 2 HISTORY OF THE GAIRDNER FOUNDATION .............................................................................................. 3 MISSION,VISION ................................................................................................................................................ 4 GOALS .................................................................................................................................................................. 5 MESSAGE FROM THE CHAIR .......................................................................................................................... 6 MESSAGE FROM THE PRESIDENT/SCIENTIFIC DIRECTOR ..................................................................... 7 2011 YEAR IN REVIEW ..................................................................................................................................... 8 REPORT ON 2011 OBJECTIVES ..................................................................................................................... 12 THE YEAR AHEAD: OBJECTIVES FOR 2012 ............................................................................................... 13 2011 SPONSORS ................................................................................................................................................ 14 GOVERNANCE
    [Show full text]
  • Medicine in Manitoba
    Medicine in Manitoba THE STORY OF ITS BEGINNINGS /u; ROSS MITCHELL, M.D. THE UNIVERSITY OF CALGARY LIBRARY FR OM THE ESTATE OF VR. E.P. SCARLETT Medic1'ne in M"nito/J" • THE STORY OF ITS BEGINNINGS By ROSS MITCHELL, M. D. .· - ' TO MY WIFE Whose counsel, encouragement and patience have made this wor~ possible . .· A c.~nowledg ments THE LATE Dr. H. H. Chown, soon after coming to Winnipeg about 1880, began to collect material concerning the early doctors of Manitoba, and many years later read a communication on this subject before the Winnipeg Medical Society. This paper has never been published, but the typescript is preserved in the medical library of the University of Manitoba and this, together with his early notebook, were made avail­ able by him to the present writer, who gratefully acknowledges his indebtedness. The editors of "The Beaver": Mr. Robert Watson, Mr. Douglas Mackay and Mr. Clifford Wilson have procured informa­ tion from the archives of the Hudson's Bay Company in London. Dr. M. T. Macfarland, registrar of the College of Physicians and Surgeons of Manitoba, kindly permitted perusal of the first Register of the College. Dr. J. L. Johnston, Provincial Librarian, has never failed to be helpful, has read the manuscript and made many valuable suggestions. Mr. William Douglas, an authority on the Selkirk Settlers and on Free' masonry has given precise information regarding Alexander Cuddie, John Schultz and on the numbers of Selkirk Settlers driven out from Red River. Sheriff Colin Inkster told of Dr. Turver. Personal communications have been received from many Red River pioneers such as Archbishop S.
    [Show full text]